Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is 0.01 as of 2026-10-06T15:50:56.652Z.
Calculation as of: 2026-10-06T15:50:56.652Z.
Quote observation: 2026-10-06T15:41:53.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: cba9556d9191d4e8e11a627d1a35b352ee16d97a5416ac9b6de76ef07ab5c9b9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
0.01
SECTOR MEDIAN · CONSUMER DEFENSIVE
0.95
median of 114 covered companies
CURRENT VS SECTOR MEDIAN
-98.95%
vs the sector median at left
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CHS Inc. (CHSCO) | $310.84M | 0.01 | N/A | N/A | N/A |
| Forafric Global PLC (AFRI)vs › | $309.27M | N/A | 0.75 | 0.87 | 1.17 |
| CHS Inc. (CHSCL)vs › | $308.52M | 0.01 | N/A | N/A | N/A |
| Lifeway Foods, Inc. (LWAY)vs › | $316.07M | 1.30 | 1.77 | 1.74 | 1.35 |
| Agencia Comercial Spirits Ltd (AGCC)vs › | $316.73M | N/A | N/A | N/A | N/A |
| CHS Inc. (CHSCP)vs › | $304.69M | 0.01 | N/A | N/A | N/A |
| CHS Inc. (CHSCN)vs › | $303.17M | 0.01 | N/A | N/A | N/A |
| CHS Inc. (CHSCM)vs › | $301.05M | 0.01 | N/A | N/A | N/A |
| Alico, Inc. (ALCO)vs › | $285.05M | 16.70 | 12.26 | 7.36 | 5.51 |
| Prenetics Global Limited (PRE)vs › | $342.22M | 2.40 | 3.12 | 2.58 | 2.08 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-08-31 | $8,605,884,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q1 FY2026Period ended 2025-11-30 | $8,864,104,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-07 |
| Q2 FY2026Period ended 2026-02-28 | $8,353,791,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-08 |
| Q3 FY2026Period ended 2026-05-31 | $11,582,089,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-08 |
| TTM revenue | $37,405,868,000 |
Current P/S: $310,838,971 market capitalization ÷ $37,405,868,000 TTM revenue = 0.01x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:41:53.000Z. Latest revenue period ended 2026-05-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
0.01
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
